RIV Capital finds support for keeping its board intact

RIV Capital finds support for keeping its board intact

The cannabis investment company’s board is one of the major reasons behind its success

The board of directors of a company is a body of major importance for the proper functioning of the legal entity, since it can be considered as the communication bridge between the company and its shareholders, whose main function is to manage the company. Institutional Shareholder Services (ISS) is quite clear about this. The second independent proxy advisory firm in RIV Capital, seeks to have shareholders vote in favor of the seven nominees for the Company’s Board of Directors.

RIV Capital is known as an investment and acquisition firm focused on building a leading multi-state platform. It currently has one of the strongest portfolios of marijuana brands in key strategic markets in the country. The board of directors is generally a key player in achieving such success, and according to ISS the current seven candidates can be of great help. ISS’ recommendation follows Glass, Lewis & Co.’s endorsement of RIV Capital’s board candidates.

Both Glass Lewis and ISS are currently the leading independent voting advisory firms responsible for providing recommendations to investment managers, pension funds, mutual funds and other institutional shareholders. Both entities gave positive recommendations, which is a clear indication of the firm’s opinion that the candidates have the knowledge, qualifications and experience necessary to join RIV Capital’s strategic team.

Laura Curran, Chris Hagedorn, Richard Mavrinac, Joseph Mimran, Amy Peckham, Mark Sims and Dawn Sweeney are the seven members listed to join the Board of Directors if approved. The next Annual General Meeting will be held on Thursday, September 29, at 10:00 AM EDT. The deadline for voting is September 27 and shareholders are urged to cast their votes before that date.